Citadel Advisors
MRM

Citadel Advisors’s MEDIROM Healthcare Technologies MRM Stock Holding History

Citadel Advisors’s Portfolio MRM Stock Details MRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8K Buy
+56,102
New +$63K ﹤0.01% 13053
2025
Q3 		– Sell
-19,217
Closed -$26.9K – 13619
2025
Q2 		$26.9K Sell
19,217
-48,211
-71% -$53.3K ﹤0.01% 12029
2025
Q1 		$24.7K Buy
+67,428
New +$53.2K ﹤0.01% 12987
2021
Q2 		– Sell
-19,626
Closed -$218K – 14118
2021
Q1 		$218K Buy
+19,626
New +$248K ﹤0.01% 11530

Other funds holding MRM

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Citadel Advisors's MRM Position: Q2 2026 in Review

Citadel Advisors opened a new position in MEDIROM Healthcare Technologies (MRM) in Q2 2026: 56,102 shares worth $57.8K. The stake represents ﹤0.01% of the portfolio and ranks #13053 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in MRM as recently as Q2 2025.

Citadel Advisors first reported a position in MRM in Q1 2021 and has held it in 4 quarters since. The position peaked at $218K in Q1 2021. 8 funds tracked by Wall St. Rank hold MRM as of Q2 2026.

  • Citadel Advisors held 56,102 shares of MEDIROM Healthcare Technologies worth $57.8K as of Q2 2026.
  • MEDIROM Healthcare Technologies was a new Citadel Advisors position in Q2 2026.
  • MEDIROM Healthcare Technologies made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13053 holding.
  • Citadel Advisors first reported a position in MEDIROM Healthcare Technologies in Q1 2021 and has held it in 4 quarters since.
  • Citadel Advisors's MEDIROM Healthcare Technologies position peaked at $218K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.